deCODE Genetics ehf.

Islande


 
Quantité totale PI 81
Rang # Quantité totale PI 16 434
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 659 438
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

6 0
2 4
69 0
0
 
Dernier brevet 2017 - Sequence variants associated wit...
Premier brevet 1999 - Human narcolepsy gene
Dernière marque 2008 - deCODEme
Première marque 2000 - DECODE GENETICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2016 Invention Sequence variants associated with prostate specific antigen levels. Certain sequence variants ha...
2015 Invention Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma...
2014 Invention Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders. The present ...
Invention Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders. The ...
Invention Genetic variants on chr 11q and 6q as markers for prostate and colorectal cancer predisposition. ...
Invention Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke. The inve...
2013 Invention Risk variants of alzheimer's disease. The T allele of the single nucleotide polymorphism rs759326...
Invention Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagn...
2012 Invention Genetic variants useful for risk assessment of thyroid cancer. Genetic variants conferring risk o...
Invention Genetic variants useful for risk assessment of arterial disease. It has been discovered that cert...
Invention Variants conferring risk of intracranial aneurysm and abdominal aortic aneurysm. It has been disc...
Invention Risk variants of prostate cancer. It has been discovered that certain genetic variants are predic...
Invention Tp53 genetic variants predictive of cancer. It has been discovered that particular variants in th...
Invention Genetic variants for predicting risk of breast cancer. The invention pertains to certain genetic...
Invention Genetic variants for predicting risk of breast cancer. The invention pertains to certain genetic ...
Invention Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders. The present inventio...
Invention Genetic susceptibility variants associated with cardiovascular disease. The invention relates to...
Invention Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders. The present i...
Invention Genetic variants useful for risk assessment of thyroid cancer. The invention discloses genetic v...
Invention Genetic variants useful for risk assessment of thyroid cancer. The invention discloses genetic va...
Invention Brip1 variants associated with risk for cancer. It has been found that variants on chromosome 17q...
Invention Variants predictive of risk of gout. Markers on chromosome 19q13, in particular, markers in the ...
Invention Variants predictive of risk of gout. Markers on chromosome 19q13, in particular, markers in the A...
Invention Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognos...
2011 Invention Genetic risk factors of sick sinus syndrome. It has been found that certain alleles of the human...
Invention Genetic risk factors of sick sinus syndrome. It has been found that certain alleles of the human ...
Invention Genetic variants in the tcf7l2 gene as diagnostic markers for risk of type 2 diabetes mellitus. ...
Invention Sequence variants associated with prostate specific antigen levels. Certain sequence variants hav...
Invention Genetic markers for risk management of vascular disease. Certain genetic markers have been found...
Invention Genetic markers for risk management of vascular disease. Certain genetic markers have been found ...
Invention Genetic variants predictive of lung cancer risk. The present invention discloses certain genetic ...
2010 Invention Genetic variants indicative of vascular conditions. The invention relates to procedures and meth...
Invention Genetic markers associated with risk of diabetes mellitus. The invention relates to variants that...
Invention Genetic markers for risk management of atrial fibrillation and stroke. The invention relates to p...
2009 Invention Genetic variants predictive of cancer risk. The invention discloses genetic variants that have b...
Invention Genetic variants predictive of cancer risk in humans. The present invention discloses genetic va...
Invention Genetic variants for breast cancer risk assessment. The invention pertains to certain genetic var...
Invention Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm. The presen...
2008 P/S Genetic identity tests comprised of reagents for genetic service use, namely analysis of genetic ...
Invention Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis...
2000 P/S Gene discovery and characterization services; pharmacogenetic services for others utilizing biote...
P/S Computer software for decision making in the delivery of health care services, for medical applic...